Shire has agreed to pay $56.5 million to settle allegations that it overstated the efficacy of several of its drugs, including the attention-deficit treatment Adderall XR, the Department of Justice said Wednesday.
via WSJ.com: US Business http://ift.tt/1v0pn4D
via WSJ.com: US Business http://ift.tt/1v0pn4D
Nessun commento:
Posta un commento